Symbol="TAK"
AssetType="Common Stock"
Name="Takeda Pharmaceutical Co Ltd ADR"
Description="Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan."
CIK="1395064"
Exchange="NYSE"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, JP"
FiscalYearEnd="March"
LatestQuarter="2023-03-31"
MarketCapitalization="6978053000000"
EBITDA="1210649936000"
PERatio="20.65"
PEGRatio="0.593"
BookValue="2043.75"
DividendPerShare="180"
DividendYield="0.0426"
EPS="202.94"
RevenuePerShareTTM="1297.67"
ProfitMargin="0.0787"
OperatingMarginTTM="0.154"
ReturnOnAssetsTTM="0.0285"
ReturnOnEquityTTM="5.27"
RevenueTTM="4027477918000"
GrossProfitTTM="2441698000000"
DilutedEPSTTM="0.7"
QuarterlyEarningsGrowthYOY="1.068"
QuarterlyRevenueGrowthYOY="0.095"
AnalystTargetPrice="19.19"
TrailingPE="22.11"
ForwardPE="9.73"
PriceToSalesRatioTTM="0.0126"
PriceToBookRatio="0.981"
EVToRevenue="0.0201"
EVToEBITDA="0.0762"
Beta="0.684"
num_52WeekHigh="17.15"
num_52WeekLow="12.28"
num_50DayMovingAverage="16.21"
num_200DayMovingAverage="15.31"
SharesOutstanding="3109060000"
DividendDate="2023-07-10"
ExDividendDate="2022-09-29"
symbol="TAK"
open="15.37"
high="15.52"
low="15.37"
price="15.48"
volume="1894854.00"
latest_trading_day="2023-07-07"
previous_close="15.44"
change="0.04"
change_percent="0.2591%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="19"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="81"
Volume_recent_avg="2121044"
Change_recent_avg="0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="81"
Aroon_momentum_negative="19"
image_negative_thumbnail_id_1="1142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0175.jpeg"
image_negative_thumbnail_id_2="514"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_neutral_thumbnail_id_1="557"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="658"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0050.jpeg"
image_positive_thumbnail_id_2="975"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
